173
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Intensive care costs of acute poisoning cases

&
Pages 457-460 | Received 15 Nov 2006, Accepted 22 Aug 2007, Published online: 20 Jan 2009

References

  • Miller TR, Lestina DC. Costs of poisoning in the United States and savings from poison control centers: a benefit-cost analysis. Ann Emerg Med 1997; 29(2)239–45
  • Noseworthy TW, Konopad E, Shustack A, Johnston R, Grace M. Cost accounting of adult intensive care: Methods and human and capital inputs. Crit Care Med 1996; 24: 1168–1172
  • Cullen DJ, Ferrara LC, Briggs BA, Walker PF, Gilbert J. Survival, hospitalization, changes and follow-up results in critically ill patients. N Engl J Med 1976; 294: 982–987
  • Classin MR. Costs and outcomes of medical intensive care. Med Care 1982; 20: 165–179
  • Wagner DP, Wineland TD, Knaus WA. The hidden costs of treating severely ill patients: Charges and resource consumption in an intensive care unit. Health Care Finance Rev 1983; 5: 81–6
  • Parviainen I, Herranen A, Holm A, Uusaro A, Ruokonen E. Results and costs of intensive care in a tertiary university hospital from 1996–2000. Acta Anaesthesiol Scand 2004; 48: 55–60
  • Jacobs P, Noseworthy TW. National estimates of intensive care costs in Canada and the United States. Crit Care Med 1990; 18: 1282–1286
  • Gyldmark M. A review of cost studies of intensive care units: problems with the cost concept. Crit Care Med 1995; 23: 964–972
  • Halpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985–2000: An analysis of bed numbers, use, and costs. Crit Care Med 2004; 32: 1254–1259
  • Celik GE, Bavbek S, Pasaoglu G, Mungan D, Abadoglu O, Harmanci E, Misirligil Z. Direct medical cost of asthma in Ankara, Turkey. Respiration 2004; 71: 587–93
  • Zencir M, Kuzu N, Beser NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer's disease in a developing country setting. Int J Geriatr Psychiatry 2005; 20: 616–22
  • Karli N, Zarifoglu M, Ertafs M, Saip S, Ozturk V, Bicakci S, Boz C, Selcuki D, Oguzhanoglu A, Neyal M, Siva A, Irkec C, Kaleagasi H, Kansu T, Sarica Y, Tasdemir N, Uzuner N. Economic impact of primary headaches in Turkey: A university hospital based study: Part II. J Headache Pain 2006; 7: 75–82
  • Erek E, Sever MS, Akoglu E, Sariyar M, Bozfakioglu S, Apaydin S, Ataman R, Sarsmaz N, Altiparmak MR, Seyahi N, Serdengecti K. Cost of renal replacement therapy in Turkey. Nephrology (Carlton) 2004; 9: 33–8
  • Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H. A cost analysis of Behçet Syndrome in Turkey. Rheumatology (Oxford) 2006; 46: 678–682
  • Parikh CR, Karnad DR. Quality, cost, and outcome of intensive care in a public hospital in Bombay, India. Crit Care Med 1999; 27(9)1754–1759
  • Cao P, Toyabe S, Abe T, Akazawa K. Profit and loss analysis for an intensive care unit (ICU) in Japan: A tool for strategic management. BMC Health Serv Res 2006; 6: 1–7
  • Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea. A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med 2001; 27: 146–153
  • Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005; 33(6)1266–71
  • Flaatten H, Kvale R. Cost of intensive care in a Norwegian university hospital 1997–1999. Crit Care 2003; 7(1)72–78
  • Edbrooke DL, Ridley SA, Hibbert CL, Corcoran M. Variations in expenditure between adult general intensive care units in the UK. Anaesthesia 2001; 56: 208–216
  • Graf J, Wagner J, Graf C, Koch KC, Janssens U. Five-year survival, quality of life, and individual costs of 303 consecutive medical intensive care patients—A cost-utility analysis. Crit Care Med 2005; 33: 547–555
  • www.tcmb.gov.tr, Central Bank of the Republic of Turkey Exchange Rates.
  • http://www.who.int/whr/2005/annexes-en.pdf, The World Health Report 2005.
  • Ramchandani P, Murray B, Hawton K, House A. Deliberate self poisoning with antidepressant drugs: A comparison of the relative hospital costs of cases of overdose of tricyclics with those of selective-serotonin re-uptake inhibitors. J Affect Disord 2000; 60(2)97–100
  • http://siteresources.worldbank.org/DATASTATISTICS/Resources/GNIPC.pdf, World Bank, World Development Indicators database–GNI per capita 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.